Prescribing of flupirtine in IMS Disease Analyser in Germany (Flupirtine drug utilisation in Germany)

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation
• Data collection methods:
  Secondary use of data

Study drug and medical condition

• Study drug International non-proprietary name (INN) or common name:
  FLUPIRTINE

Population studied

• Short description of the study population:
  Patients with a prescription for flupirtine.
• Age groups:
  • Preterm newborn infants (0 – 27 days)
  • Term newborn infants (0 – 27 days)
  • Infants and toddlers (28 days – 23 months)
  • Children (2 to < 12 years)
  • Adolescents (12 to < 18 years)
  • Adults (18 to < 46 years)
  • Adults (46 to < 65 years)
  • Adults (65 to < 75 years)
  • Adults (75 to < 85 years)
  • Adults (85 years and over)
• Estimated number of subjects:
  200000

Study design details

• Main study objective:
  To study prescribing of flupirtine by prescriber category, gender, age, and time period.
• Data analysis plan:
  Number of patients and number of prescriptions